US Tech 100

19,881.20

0.18%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NPSP

Nps (NPSP)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NPSP

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
12/04/2014	8:10AM	Business Wire	NPS Pharma to Present at Oppenheimer Healthcare Conference	NASDAQ:NPSP	(MM)
12/02/2014	12:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
12/02/2014	9:16AM	Business Wire	European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypopara...	NASDAQ:NPSP	(MM)
11/25/2014	4:10PM	Business Wire	NPS Pharma to Present at Deutsche Bank BioFEST Conference	NASDAQ:NPSP	(MM)
11/25/2014	1:08PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:NPSP	(MM)
11/24/2014	8:10AM	Business Wire	Teduglutide Granted Orphan Drug Designation in Japan	NASDAQ:NPSP	(MM)
11/19/2014	3:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
11/13/2014	3:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
11/11/2014	4:10PM	Business Wire	NPS Pharma to Present at Jefferies Global Healthcare Conference	NASDAQ:NPSP	(MM)
11/10/2014	4:31PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NPSP	(MM)
11/10/2014	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
11/10/2014	4:01PM	Business Wire	NPS Pharma Reports Third-Quarter 2014 Financial Results	NASDAQ:NPSP	(MM)
11/05/2014	11:42AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
11/05/2014	11:41AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:NPSP	(MM)
11/04/2014	4:37PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
11/04/2014	4:30PM	Business Wire	NPS Pharma Appoints Pierre Legault to Board of Directors	NASDAQ:NPSP	(MM)
11/04/2014	3:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
11/03/2014	8:10AM	Business Wire	NPS Pharma to Report Third Quarter 2014 Financial Results	NASDAQ:NPSP	(MM)
10/29/2014	11:59AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
10/24/2014	9:33AM	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NASDAQ:NPSP	(MM)
10/23/2014	4:34PM	Business Wire	PDUFA Action Date for Natpara® BLA Extended Three Months to January 24, 2015	NASDAQ:NPSP	(MM)
10/17/2014	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
09/30/2014	11:18AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NPSP	(MM)
09/24/2014	4:10PM	Business Wire	NPS Pharma to Present at Leerink Partners Rare Disease Roundtable	NASDAQ:NPSP	(MM)
09/16/2014	12:13AM	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NASDAQ:NPSP	(MM)
09/12/2014	6:15PM	Business Wire	FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism	NASDAQ:NPSP	(MM)
09/12/2014	5:29PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NPSP	(MM)
09/12/2014	5:06PM	Business Wire	FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism	NASDAQ:NPSP	(MM)
09/12/2014	7:06AM	Business Wire	NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara® Biologics License Application	NASDAQ:NPSP	(MM)
09/10/2014	8:04AM	Business Wire	FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara® for Hypoparathyroidism	NASDAQ:NPSP	(MM)